158 related articles for article (PubMed ID: 17215578)
1. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
[TBL] [Abstract][Full Text] [Related]
2. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
3. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
Hannesdóttir K; Snaedal J
Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
Suh GH; Ju YS; Yeon BK; Shah A
Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease.
Burns A; Spiegel R; Quarg P
Int J Geriatr Psychiatry; 2004 Mar; 19(3):243-9. PubMed ID: 15027039
[TBL] [Abstract][Full Text] [Related]
7. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
Graham DP; Cully JA; Snow AL; Massman P; Doody R
Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
[TBL] [Abstract][Full Text] [Related]
8. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of rate of loss of autonomy in Alzheimer's disease patients. A prospective study of the REAL.FR Cohort.
Lechowski L; De Stampa M; Tortrat D; Teillet L; Benoit M; Robert PH; Vellas B;
J Nutr Health Aging; 2005; 9(2):100-4. PubMed ID: 15791353
[TBL] [Abstract][Full Text] [Related]
10. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment.
Vellas B; Lauque S; Gillette-Guyonnet S; Andrieu S; Cortes F; Nourhashémi F; Cantet C; Ousset PJ; Grandjean H;
J Nutr Health Aging; 2005; 9(2):75-80. PubMed ID: 15791349
[TBL] [Abstract][Full Text] [Related]
11. Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations.
Doraiswamy PM; Bieber F; Kaiser L; Connors K; Krishnan KR; Reuning-Scherer J; Gulanski B
Psychopharmacol Bull; 1997; 33(1):123-8. PubMed ID: 9133763
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological predictors of dependency in patients with Alzheimer disease.
Sarazin M; Stern Y; Berr C; Riba A; Albert M; Brandt J; Dubois B
Neurology; 2005 Mar; 64(6):1027-31. PubMed ID: 15781821
[TBL] [Abstract][Full Text] [Related]
13. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
Matsuda A; Kazui H; Hirono N; Mori E
No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS - cog, SKT and MMSE.
Ihl R; Grass-Kapanke B; Jänner M; Weyer G
Pharmacopsychiatry; 1999 Nov; 32(6):248-54. PubMed ID: 10599935
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of T(2) relaxation times of hippocampus and amygdala in Alzheimer's disease.
Wang H; Yuan H; Shu L; Xie J; Zhang D
Neurosci Lett; 2004 Jun; 363(2):150-3. PubMed ID: 15172104
[TBL] [Abstract][Full Text] [Related]
16. Role of behavioural disturbance in the loss of autonomy for activities of daily living in Alzheimer patients.
Lechowski L; Dieudonné B; Tortrat D; Teillet L; Robert PH; Benoit M; Forette B; Vellas B;
Int J Geriatr Psychiatry; 2003 Nov; 18(11):977-82. PubMed ID: 14618547
[TBL] [Abstract][Full Text] [Related]
17. [The cognitive deficits in the late-life depression and their prognostic value for pharmacotherapy].
Sołtys K; Bidzan L; Turczyński J; Łapin J
Psychiatr Pol; 2002; 36(6 Suppl):167-76. PubMed ID: 12647436
[TBL] [Abstract][Full Text] [Related]
18. ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)--validation of the Slovak version.
Kolibas E; Korinkova V; Novotny V; Vajdickova K; Hunakova D
Bratisl Lek Listy; 2000; 101(11):598-602. PubMed ID: 11218956
[TBL] [Abstract][Full Text] [Related]
19. The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials.
Doraiswamy PM; Bieber F; Kaiser L; Krishnan KR; Reuning-Scherer J; Gulanski B
Neurology; 1997 Jun; 48(6):1511-7. PubMed ID: 9191757
[TBL] [Abstract][Full Text] [Related]
20. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes.
Suh GH; Kil Yeon B; Shah A; Lee JY
Int J Geriatr Psychiatry; 2005 Jan; 20(1):26-34. PubMed ID: 15578675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
